AG
TXG icon

AIA Group’s 10x Genomics TXG Stock Holding History

AIA Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-41,369
Closed -$2.32M – 346
2023
Q4 		$2.32M Buy
41,369
+365
+0.9% +$15.9K 0.1% 110
2023
Q3 		$1.69M Buy
41,004
+6,099
+17% +$317K 0.08% 113
2023
Q2 		$1.95M Buy
34,905
+11,010
+46% +$596K 0.09% 104
2023
Q1 		$1.33M Buy
23,895
+13,679
+134% +$639K 0.07% 122
2022
Q4 		$372K Sell
10,216
-7,450
-42% -$244K 0.02% 258
2022
Q3 		$503K Buy
17,666
+530
+3% +$20.2K 0.03% 190
2022
Q2 		$775K Buy
17,136
+1,976
+13% +$103K 0.04% 178
2022
Q1 		$1.15M Sell
15,160
-16,177
-52% -$1.42M 0.05% 156
2021
Q4 		$4.67M Buy
31,337
+9,053
+41% +$1.39M 0.22% 61
2021
Q3 		$3.24M Buy
22,284
+4,317
+24% +$741K 0.18% 73
2021
Q2 		$3.1M Buy
+17,967
New +$3.25M 0.21% 67

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AIA Group's TXG Position: Q1 2024 in Review

AIA Group sold out of 10x Genomics (TXG) in Q1 2024, closing a stake of 41,369 shares — an estimated $2.32M sold.

AIA Group first reported a position in TXG in Q2 2021 and held it in 11 quarters. The position peaked at $4.67M in Q4 2021. 290 funds tracked by Wall St. Rank hold TXG as of Q1 2024.

  • AIA Group reported no remaining 10x Genomics position as of Q1 2024 after selling out during the quarter.
  • AIA Group sold 41,369 10x Genomics shares in Q1 2024, an estimated $2.32M.
  • AIA Group first reported a position in 10x Genomics in Q2 2021 and held it in 11 quarters.
  • AIA Group's 10x Genomics position peaked at $4.67M in Q4 2021.
  • 290 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2024.

Based on AIA Group's 13F filing for Q1 2024, filed 6 May 2024.